Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenic trioxide results in increased expression of HSPA6 mRNA] | decreases reaction|increases expression | 15978632
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenic trioxide results in increased expression of HSPA6 protein] | decreases reaction|increases expression | 15978632
|
C006632 |
arsenic trioxide |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenic trioxide results in increased expression of HSPA6 mRNA] | decreases reaction|increases expression | 15978632
|
C006632 |
arsenic trioxide |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenic trioxide results in increased expression of HSPA6 protein] | decreases reaction|increases expression | 15978632
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of HSPA6 mRNA | increases expression | 19417148 15978632
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of HSPA6 protein | increases expression | 15978632 19364129
|
C006632 |
arsenic trioxide |
MAP2K4 protein promotes the reaction [arsenic trioxide results in increased expression of HSPA6 mRNA] | increases expression|increases reaction | 15978632
|
C006632 |
arsenic trioxide |
MAP2K4 protein promotes the reaction [arsenic trioxide results in increased expression of HSPA6 protein] | increases expression|increases reaction | 15978632
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of HSPA6 mRNA | increases expression | 18687144
|
D001374 |
Azacitidine |
Azacitidine results in increased expression of HSPA6 mRNA | increases expression | 19194470
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of HSPA6 mRNA | decreases expression | 16029874
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of HSPA6 mRNA | increases expression | 12414654
|
D002104 |
Cadmium |
Cadmium results in increased expression of HSPA6 mRNA | increases expression | 21172416
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of HSPA6 mRNA | increases expression | 20106945
|
D003561 |
Cytarabine |
Cytarabine results in increased expression of HSPA6 mRNA | increases expression | 19194470
|
C014347 |
decitabine |
decitabine results in increased expression of HSPA6 mRNA | increases expression | 19194470
|
D013759 |
Tetrahydrocannabinol |
Tetrahydrocannabinol results in decreased expression of HSPA6 mRNA | decreases expression | 16039398
|
D004137 |
Dinitrochlorobenzene |
Dinitrochlorobenzene results in increased expression of HSPA6 mRNA | increases expression | 16314067
|
D004178 |
Diquat |
Diquat results in increased expression of HSPA6 mRNA | increases expression | 21172416
|
D004391 |
Dust |
Dust results in increased expression of HSPA6 mRNA | increases expression | 17805423
|
D004958 |
Estradiol |
Estradiol results in decreased expression of HSPA6 mRNA | decreases expression | 16029874
|
D004958 |
Estradiol |
Estradiol results in increased expression of HSPA6 mRNA | increases expression | 20106945
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of HSPA6 mRNA | affects cotreatment|increases expression | 17404688
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of HSPA6 mRNA | increases expression | 12414654
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of HSPA6 mRNA | increases expression | 16314067
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of HSPA6 mRNA | affects cotreatment|increases expression | 17404688
|
C515055 |
S-(dimethylarsino)-glutathione |
S-(dimethylarsino)-glutathione results in increased expression of HSPA6 mRNA | increases expression | 19417148
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HSPA6 mRNA | increases expression | 16966095 12760830
|
C025462 |
sulindac sulfide |
sulindac sulfide results in increased expression of HSPA6 mRNA | increases expression | 16184548
|
D013849 |
Thimerosal |
Thimerosal results in increased expression of HSPA6 mRNA | increases expression | 16870260
|
D024483 |
Vitamin K 3 |
Vitamin K 3 results in increased expression of HSPA6 mRNA | increases expression | 12414654
|
D015032 |
Zinc |
Zinc results in increased expression of HSPA6 mRNA | increases expression | 16870260
|
C016837 |
zinc chloride |
zinc chloride results in increased expression of HSPA6 mRNA | increases expression | 16870260
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.21 | 17190629 16889938 17202136 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
4.13 | 19131640 12718980 11954676 16100012 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.23 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.23 | 11473722 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.51 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.71 | 16712894 17306315 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
4.54 | 18759972 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
4.54 | 16325427 16580781 17119284 16410023 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Tetrahydrocannabinol |
4.71 | 15204022 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.72 | 16916123 |
MESH:D001249 |
Asthma |
|
Zinc |
2.90 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
7.10 | 15687053 |
MESH:D050197 |
Atherosclerosis |
|
Tetrahydrocannabinol |
7.10 | 15815632 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.50 | 16206674 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.69 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.14 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
10.41 | 15665606 15380490 15845082 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
10.41 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.96 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.96 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.96 | 19861407 12948864 17018787 17289903 18497071 17261762 16675129 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.96 | 15562024 16175315 17614352 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.15 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.27 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
6.38 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
6.38 | 16217749 11135700 14691202 15073043 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.38 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.38 | 16507464 17306315 15276417 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.80 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.38 | 12391285 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.68 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.95 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.33 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.33 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
7.33 | 16543248 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
7.22 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
7.22 | 16936243 |
MESH:D002375 |
Catalepsy |
|
Tetrahydrocannabinol |
5.53 | 10318961 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
19.75 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
19.75 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
19.75 | 8243401 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
19.75 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
19.75 | 19524636 20056578 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.78 | 19486331 |
MESH:D003093 |
Colitis, Ulcerative |
|
Dinitrochlorobenzene |
3.79 | 19159591 17373747 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.30 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.47 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
3.47 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.47 | 18981723 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.00 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.84 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
2.84 | 19302082 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.92 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dinitrochlorobenzene |
10.93 | 15491423 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
10.93 | 16823706 11298694 16780908 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Thimerosal |
10.93 | 15932584 16958921 |
MESH:D002658 |
Developmental Disabilities |
|
Thimerosal |
4.71 | 15764492 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.04 | 16479319 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.25 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.30 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diquat |
3.44 | 18164269 18445702 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.60 | 17692515 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.92 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.86 | 11473722 19148513 18566989 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.60 | 16134523 |
MESH:D004827 |
Epilepsy |
|
Tetrahydrocannabinol |
4.39 | 821787 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.58 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
4.58 | 16543248 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.18 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.18 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
2.95 | 12639820 12168785 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.08 | 16904648 |
MESH:D005756 |
Gastritis |
|
Diquat |
11.22 | 15046732 |
MESH:D005756 |
Gastritis |
|
Zinc |
11.22 | 17241300 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.49 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.03 | 8708960 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.84 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.36 | 19215824 |
MESH:D006333 |
Heart Failure |
|
Zinc |
3.49 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.58 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.35 | 17241300 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.23 | 15720958 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.50 | 17276780 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.84 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
7.32 | 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
7.32 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.56 | 17088409 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.03 | 10903974 |
MESH:D007035 |
Hypothermia |
|
Tetrahydrocannabinol |
5.73 | 10318961 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.21 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
10.74 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Diquat |
10.74 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
10.74 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.51 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.03 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.03 | 16393666 16627594 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.44 | 16584753 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.25 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
17.92 | 16962696 16322080 16226777 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
17.92 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
17.92 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
17.92 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
17.92 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
9.65 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
9.65 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.76 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.76 | 15610895 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
10.08 | 15070760 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
10.08 | 19148494 |
MESH:D007938 |
Leukemia |
|
decitabine |
10.08 | 18980019 19235587 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.62 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
11.13 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
11.13 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.29 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
15.12 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
15.12 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
15.12 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
6.06 | 17050201 16467208 20471514 19850784 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
6.06 | 17596541 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
6.06 | 18460780 19387464 17679729 18704418 19010910 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.27 | 18055864 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.01 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.09 | 17869043 16823087 15748426 17649720 16330433 12712474 16966277 17712046 11468182 19035177 17217047 9834237 11161223 17107899 19225113 16891316 15622746 15213294 16331271 16112521 12018890 19642359 12679006 19075265 15336539 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.17 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.67 | 14659978 14716833 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
4.44 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
4.44 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
2.62 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.21 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.05 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.84 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.48 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
3.48 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.48 | 17306315 19931552 16712894 15276417 17077188 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.28 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.36 | 11807958 11408345 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.36 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
9.36 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.29 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
7.14 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Dinitrochlorobenzene |
7.14 | 17334785 12202904 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.14 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Vitamin K 3 |
7.14 | 19082730 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.11 | 16166281 16966607 18303189 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.59 | 16801185 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.89 | 19299654 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
16.29 | 19417148 14977855 15949261 11468182 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
16.29 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
16.29 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
S-(dimethylarsino)-glutathione |
16.29 | 19417148 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.48 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
11.84 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
11.84 | 18720364 17611569 19805378 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
11.84 | 19010910 16882708 19157545 18608210 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.13 | 16810080 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.78 | 16624393 |
MESH:D009369 |
Neoplasms |
|
decitabine |
4.91 | 19470736 19116145 17925555 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.91 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.48 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.54 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.25 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.12 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.13 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.13 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
11.66 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.66 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tetrahydrocannabinol |
11.66 | 19040278 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.80 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
14.33 | 19769630 12452020 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
14.33 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.33 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
14.33 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
14.33 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.17 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.17 | 19294695 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.90 | 12065085 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.98 | 19927285 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.19 | 15687053 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.70 | 10923243 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.06 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
4.34 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.03 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
3.76 | 10548101 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.54 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.98 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.98 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.08 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
2.08 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.08 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.08 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.08 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.08 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
2.08 | 16700911 16517595 16606632 12429649 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.59 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.96 | 17975199 17365031 15814490 17322281 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
3.98 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.22 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.79 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.78 | 16646077 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
9.06 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.06 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.06 | 8532709 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.09 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.65 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.52 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.52 | 19037991 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.79 | 16684133 16045194 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
6.84 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
6.84 | 17967635 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.49 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.23 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.77 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
7.96 | 12845720 20435036 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
7.96 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.96 | 11723127 17306315 16452187 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.60 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.82 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
4.47 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.72 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.79 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.23 | 17056641 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.25 | 17120751 |